Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2020
/
Article
/
Tab 2
/
Research Article
Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury
Table 2
Relationship between serum CCL21 and MoCA.
Variable
Serum CCL21 levels (pg/ml)
Q1
Q2
Q3
Q4
MoCA (point)
0.023
CCL21: chemokine (C-C motif) ligand 21; MoCA: Montreal Cognitive Assessment.